---
title: "First patient randomised in BACKBEAT study of AVIM therapy for uncontrolled hypertension"
date: "2024-01-12T17:15:46.000Z"
publishedDate: "12 janvier 2024"
summary: "Orchestra BioMed Holdings has announced the first patient was randomised in the BACKBEAT pivotal study in late December 2023. The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (AVIM) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications."
importance: ""
sourceUrl: "https://cardiovascularnews.com/first-patient-randomised-in-backbeat-study-of-avim-therapy-for-uncontrolled-hypertension/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-12-first-patient-randomised-in-backbeat-study-of-avim-therapy-for-uncontrolled-hypertension"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/06/blood-pressure.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patient-randomised-in-backbeat-study-of-avim-therapy-for-uncontrolled-hypertension/"
---

![First patient randomised in BACKBEAT study of AVIM therapy for uncontrolled hypertension](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/06/blood-pressure.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/first-patient-randomised-in-backbeat-study-of-avim-therapy-for-uncontrolled-hypertension/*

## L’essentiel

Orchestra BioMed Holdings has announced the first patient was randomised in the BACKBEAT pivotal study in late December 2023. The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (AVIM) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications.

## Lien source

https://cardiovascularnews.com/first-patient-randomised-in-backbeat-study-of-avim-therapy-for-uncontrolled-hypertension/
